Gradientech closes fully subscribed USD 4.6million rights issue to progress QuickMIC™ diagnostic system for ultra-rapid AST testing
Uppsala, Sweden, April 4, 2019. Swedish biotechnology company Gradientech today announced it has closed a fully subscribed rights issue totalling USD 4.6 million (SEK 42.5 million).Existing owners, as well as new parties appointed by Erik Penser Bank AB, who acted as financial advisor, have subscribed. Bird & Bird Lawyers acted as legal advisors.Dr Sara Thorslund, CEO of Gradientech says: “We have now successfully completed Gradientech's largest rights issue, which provides capital for continued development and early market introduction of our QuickMIC™ diagnostic system. Our system is